Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 59.33% is in line with its 5-year average of 55.44%, near the high end of its 5-year range (53.47%–59.33%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.28% above its 12-month average of 55.83%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
59.33%
GROSS MARGIN AVG TTM
55.83%
GROSS MARGIN AVG 3Y
55.39%
GROSS MARGIN AVG 5Y
55.44%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+6.28%
CURRENT VS 3Y AVG
+7.12%
CURRENT VS 5Y AVG
+7.02%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
60.23%
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
-1.49%
vs the sector median at left
Market Cap
$32.38B
Gross Margin
42.90%
TTM Avg
40.85%
3Y Avg
40.34%
5Y Avg
40.27%
Market Cap
$31.37B
Gross Margin
79.72%
TTM Avg
83.69%
3Y Avg
83.53%
5Y Avg
83.62%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alcon Inc. (ALC) | $34.88B | 59.33% | 55.83% | 55.39% | 55.44% |
| ResMed Inc. (RMD)vs › | $34.60B | 61.16% | 60.26% | 58.24% | 57.85% |
| DexCom, Inc. (DXCM)vs › | $34.13B | 62.47% | 60.28% | 62.12% | 63.92% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $32.38B | 42.90% | 40.85% | 40.34% | 40.27% |
| Zoetis Inc. (ZTS)vs › | $32.15B | 70.87% | 69.79% | 68.91% | 68.46% |
| Biogen Inc. (BIIB)vs › | $32.10B | 67.71% | 73.30% | 74.61% | 77.63% |
| Centene Corp. (CNC)vs › | $31.95B | 16.13% | 11.28% | 11.33% | 11.71% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $31.37B | 79.72% | 83.69% | 83.53% | 83.62% |
| Waters Corporation (WAT)vs › | $31.00B | 50.78% | 58.60% | 58.69% | 58.45% |
| Medline Inc. (MDLN)vs › | $29.72B | 25.02% | 25.55% | 23.71% | 23.71% |
Gross Margin
59.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 59.33% |
| 2026-03-31 | 56.36% |
| 2025-12-31 | 54.19% |
| 2025-09-30 | 55.78% |
| 2025-06-30 | 53.47% |
| 2025-03-31 | 55.92% |
| 2024-12-31 | 55.36% |
| 2024-09-30 | 55.87% |
| 2024-06-30 | 55.05% |
| 2024-03-31 | 56.20% |
| 2023-12-31 | 54.85% |
| 2023-09-30 | 55.35% |
| 2023-06-30 | 56.28% |
| 2023-03-31 | 55.48% |
| 2022-12-31 | 53.89% |
| 2022-09-30 | 54.49% |
| 2022-06-30 | 54.31% |
| 2022-03-31 | 55.19% |
| 2021-12-31 | 56.12% |
| 2021-09-30 | 56.85% |
| 2021-06-30 | 57.82% |
| 2021-03-31 | 53.42% |
| 2020-12-31 | 45.10% |
| 2020-09-30 | 46.14% |
| 2020-06-30 | 28.42% |
| 2020-03-31 | 47.37% |
| 2019-12-31 | 48.14% |
| 2019-09-30 | 50.86% |
| 2019-06-30 | 49.76% |
| 2019-03-31 | 46.71% |
| 2018-12-31 | 48.58% |
| 2018-09-30 | 32.24% |
| 2018-06-30 | 48.24% |
| 2018-03-31 | 48.17% |
| 2017-12-31 | 45.97% |
